Novartis will continue to do bolt-on deals and its capital allocation priorities remain unchanged, CEO Vasant Narasimhan said ...
Novartis recently announced it has reached an agreement with the U.S. government that aims to lower the price of innovative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback